+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effect of oligosaccharide chain length exposed terminal group and hapten loading on the antibody response of human adults and infants to vaccines consisting of haemophilus influenzae type b capsular antigen uniterminally coupled to the diphtheria protein crm197



Effect of oligosaccharide chain length exposed terminal group and hapten loading on the antibody response of human adults and infants to vaccines consisting of haemophilus influenzae type b capsular antigen uniterminally coupled to the diphtheria protein crm197



Journal of Immunology 142(7): 2464-2468



Vaccines consisting of oligosaccharide (OS) derived from Haemophilus influenzae type b capsular polysaccharide and conjugated to carrier proteins had been shown capable of eliciting memory-type capsular polysaccharide of H. influenza type b antibody responses in human infants, but the structural variables governing immunogenicity were not defined. Here a series of conjugates were made with the diphtheria protein CRM197 and with uniterminally coupled OS haptens that varied in chain length, exposed terminal residue, or multiplicity of loading as defined by ribose/protein ratio. Adults were given a single injection, 1-yr-old infants were given a two-injection sequence, and capsular polysaccharide of H. influenzae type b antibody responses were assessed by radioantigen binding. Vaccines C-4r, C-6r, and C-12r, in which ribitol-ended OS of mean length 4, 6, or 12 repeat units were coupled at low hapten loading, were about equally immunogenic (geometric means 2 to 5 .mu.g/ml in infants, 5 to 9 .mu.g/ml in adults). Vaccine C7p was made with a higher loading of OS having mean length 7 repeat units and having mainly phosphate monoester at the exposed termini Vaccine C-7R was made from a portion of C-7p by enzymatic removal of most of the terminal phosphates. Compared to the C-4r, C-6r, and C-12r series, vaccines C-7p and C-7R induced geometric means about 10-fold higher in adults and 20-fold higher in infants. Thus OS chain length (in the range studied) and exposed terminus are less critical variables in this system than the extent of hapten loading.

(PDF emailed within 1 workday: $29.90)

Accession: 007255057

Download citation: RISBibTeXText

PMID: 2784464


Related references

Effect of oligosaccharide os chain length terminal group and hapten loading on the serum antibody ab response of 1 yr old infants to haemophilus influenzae b capsular antigen prp conjugated to the diphtheria protein crm197. Pediatric Research 21(4 PART 2): 321A, 1987

Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy. Archives of Pediatrics & Adolescent Medicine 148(6): 620-625, 1994

Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197. Journal of Clinical Investigation 76(1): 52-59, 1985

Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization. Archives of Medical Research 27(4): 539-545, 1996

Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants. Journal of Experimental Medicine 163(2): 262-269, 1986

Protein oligosaccharide conjugate vaccine primes infants for a mature antibody response to the capsular polysaccharide of haemophilus influenzae type b. Pediatric Research 19(4 PART 2): 286A, 1985

Effect of phosphate ester residues on the immunogenicity of CRM197-coupled Haemophilus influenzae type b capsular saccharides in 2-month-old infants. Journal of Infectious Diseases 165 Suppl 1: S160-S161, 1992

Enhanced antibody responses to the capsular antigen of haemophilus influenzae type b in infants vaccinated with oligosaccharides coupled to a protein carrier. Jackson, G G And H Thomas (Ed ) Bayer-Symposium, Vol 8 The Pathogenesis Of Bacterial Infections; Schloss Gracht, West Germany, May 29-June 2, 1984 Xvi+431p Springer-Verlag: Berlin, West Germany; New York, N Y , Usa Illus 419-421, 1985

Comparison of anti prp antibody response between single vaccination with haemophilus influenzae type b oligosaccharide crm197 conjugate vaccine in 16 20 mo. old infants and single vaccination with haemophilus beta polysaccharide vaccine prp in 24 26 mo. old infants. Pediatric Research 23(4 PART 2): 380A, 1988

Mucosal and serum antibody ab responses to parenteral immunization of 1 yr old infants with haemophilus influenzae b capsular prp antigen conjugated to a diphtheria protein carrier. Pediatric Research 21(4 PART 2): 338A, 1987

Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccines. Vaccine 19(23-24): 3189-3200, 30 April, 2001

Increased antibody response to immunization with haemophilus influenzae type b and pneumococcal capsular poly saccharide vaccines in adults with the g 2mn allotype. Pediatric Research 16(4 PART 2): 234A, 1982

Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines. American Journal of Diseases of Children 145(8): 898-900, 1991

Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infection and Immunity 39(1): 233-238, 1983

MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine. Infection and Immunity 65(5): 1710-1715, 1997